Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Directorate Change

14th May 2014 07:00

RNS Number : 0166H
Ultrasis PLC
14 May 2014
 

Ultrasis plc

("Ultrasis" or the "Company")

 

Directorate change

 

 

Ultrasis plc today announces the appointment of Alan Kershaw as Finance Director. The appointment is effective from 2 June 2014, when he will also join the Board.

 

Alan was previously Finance & Operations Director at WH Ireland Group plc and prior to that worked at JP Morgan and Royal Liver Assurance. He qualified as a Chartered Accountant with PricewaterhouseCoopers.

John Smith, Chief Executive of Ultrasis, said "'We are delighted that Alan has agreed to join the Board at this exciting time. He brings with him significant board level strategic finance experience, latterly as Finance and Operations Director at WH Ireland."

He added "The Company continues to make progress towards profitability and we will continue to develop the business through further acquisitions and contract wins. Alan will focus on ensuring robust financial planning is in place and helping to secure further investment in the Group."

The following information regarding the appointment of Alan Mark Kershaw (aged 47) is required to be disclosed under Schedule 2(g) of the AIM Rules:

 

Other directorships held:

 

Current:

Within the last five years:

none

WH Ireland Group plc

W.H. Ireland Trustee Limited

W.H. Ireland Limited

A.R.E. Business & Professional Limited

S.R.S. Business & Professional Limited

W.H. Ireland (Financial Services) Limited

Fitel Nominees Limited

W.H. Ireland Nominees Limited

Readycount Limited

Stockholm Investments Limited

W.H. Ireland (Stockbrokers) Limited*

W.H. Ireland Leasing Limited*

 

*dissolved while Mr. Kershaw was a Director

 

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules.

Media enquiries:

For all enquiries relating to Ultrasis please contact:

 

Ultrasis plc

Tel: +44 (0) 20 7535 2050

John Smith, Chief Executive

 

finnCap Limited

 

Tel: +44 (0) 20 7220 0500

Geoff Nash/Simon Hicks

 

JBP Public Relations

 

Tel: +44 (0) 11 7907 3400

Chris Lawrance

 

Notes to Editors:

Ultrasis is a healthcare company with core expertise in health, psychology, software development and programme management. We deliver a range of healthcare products to the consumer, the NHS, the corporate sector and other healthcare providers in the UK and Internationally. Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy (CBT) and interactive multimedia, and is still the world leader in this field.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAAJMATMBTBBTI

Related Shares:

Ultrasis Plc
FTSE 100 Latest
Value8,275.66
Change0.00